<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">Terapevticheskii arkhiv</journal-id><journal-title-group><journal-title xml:lang="en">Terapevticheskii arkhiv</journal-title><trans-title-group xml:lang="ru"><trans-title>Терапевтический архив</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0040-3660</issn><issn publication-format="electronic">2309-5342</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">31211</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Editorial article</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Передовая статья</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">How validly to assume pulmonary thromboembolism: How diagnostic scales help</article-title><trans-title-group xml:lang="ru"><trans-title>Как обоснованно сделать предположение о наличии тромбоэмболии легочных артерий: насколько помогают диагностические шкалы</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Mironov</surname><given-names>A V</given-names></name><name xml:lang="ru"><surname>Миронов</surname><given-names>А В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Leont'ev</surname><given-names>S G</given-names></name><name xml:lang="ru"><surname>Леонтьев</surname><given-names>С Г</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ustinov</surname><given-names>F S</given-names></name><name xml:lang="ru"><surname>Устинов</surname><given-names>Ф С</given-names></name></name-alternatives><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Efremova</surname><given-names>O I</given-names></name><name xml:lang="ru"><surname>Ефремова</surname><given-names>О И</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lebedev</surname><given-names>I S</given-names></name><name xml:lang="ru"><surname>Лебедев</surname><given-names>И С</given-names></name></name-alternatives><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kirienko</surname><given-names>A I</given-names></name><name xml:lang="ru"><surname>Кириенко</surname><given-names>А И</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1"><institution>Российский научно-исследовательский медицинский университет им. Н.И. Пирогова Минздрава РФ</institution></aff><aff id="aff2"><institution>ГКБ №1 им. Н.И. Пирогова, Москва</institution></aff><pub-date date-type="pub" publication-format="electronic" iso-8601-date="2013-04-15"><day>15</day><month>04</month><year>2013</year></pub-date><pub-date date-type="collection"><year>2013</year></pub-date><volume>85</volume><issue>4</issue><issue-title xml:lang="en">VOL 85, NO4 ()</issue-title><issue-title xml:lang="ru">ТОМ 85, №4 (2013)</issue-title><fpage>11</fpage><lpage>15</lpage><history><date date-type="received" iso-8601-date="2020-04-10"><day>10</day><month>04</month><year>2020</year></date></history><pub-history><event event-type="received"><event-desc>Received:<date date-type="received" iso-8601-date="2020-04-10"><day>10</day><month>04</month><year>2020</year></date></event-desc></event><event event-type="pub"><event-desc>Published:<pub-date date-type="pub" publication-format="electronic" iso-8601-date="2013-04-15"><day>15</day><month>04</month><year>2013</year></pub-date></event-desc></event></pub-history><permissions><copyright-statement xml:lang="en">Copyright ©; 2013, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2013, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://ter-arkhiv.ru/0040-3660/article/view/31211">https://ter-arkhiv.ru/0040-3660/article/view/31211</self-uri><abstract xml:lang="en"><p>AIM: To detect the most important clinical symptoms suggesting pulmonary thromboembolism (PTE) and to determine the diagnostic value of the scales used to estimate the likelihood of its occurrence. Materials and methods. The prospective study included 130 patients admitted to hospital with a diagnosis of PTE and a referral for a surgery clinic. Scores of the likelihood of PTE were estimated using the Canada and Geneva scales in all the patients on admission/RESULTS: In all the patients with suspected PTE, the Canadian and revised Geneva scores averaged 4.2±0.48 and 6.21±0.5, respectively. These scores correspond to the intermediate clinical probability of PTE. In 96 patients whose diagnosis was verified by instrumental studies, the Canadian and Geneva scores were 4.41±0.57 and 6.17±0.63, respectively, which was also consistent with the intermediate clinical probability of PTE. In 34 patients, whose diagnosis of PTE was ruled out, the average scores did not virtually differ from those in the patients with the verified diagnosis and were 6.14±1.3 and 4.18±0.87, respectively. The area under characteristic curve for the Canadian scale was 0.428 and that for the Geneva scale was 0.512. With the use of a two-level interpretation system, a total of more than 6 Canadian scores and 10 Geneva scores suggested that there was a high probability of PTE/CONCLUSION: The investigation indicated the low value of integral systems for estimating the likelihood of PTE in the total population of patients with this disease. The authors recommend the two-level interpretation system, in which a total of more than 6 Canadian scores and 10 Geneva scores were identified with a high probability (up to 80%) of PTE.</p></abstract><trans-abstract xml:lang="ru"><p>Резюме. Цель исследования. Выявление наиболее значимых клинических симптомов, позволяющих предположить наличие тромбоэмболии легочных артерий (ТЭЛА), и определение диагностического значения шкал, предназначенных для оценки вероятности ее возникновения. Материалы и методы. В проспективное исследование включили 130 пациентов, которых госпитализировали с направительным диагнозом ТЭЛА в хирургическую клинику. У всех пациентов при поступлении проводили балльную оценку вероятности развития ТЭЛА по Канадской и Женевской шкалам. Результаты. У всех пациентов с подозрением на ТЭЛА оценки по Канадской шкале и пересмотренной Женевской шкале в среднем составляли 4,2±0,48 и 6,21±0,5 балла соответственно. Такие оценки соответствуют промежуточной клинической вероятности наличия ТЭЛА. У 96 пациентов, у которых диагноз подтвержден с помощью инструментальных методов, оценка по Канадской шкале составляла 4,41±0,57 балла, по Женевской шкале - 6,17±0,63 балла, что также соответствовало промежуточной клинической вероятности наличия ТЭЛА. У 34 пациентов, у которых диагноз ТЭЛА был исключен, средняя оценка практически не отличалась от таковой, полученной у больных с верифицированным диагнозом, и составляла соответственно 6,14±1,3 и 4,18±0,87 балла. Площадь по характеристической кривой (AUC) для Канадской шкалы составляла 0,428 и для Женевской шкалы - 0,512. При двухуровневой системе интерпретации суммарная оценка более 6 баллов по Канадской шкале и 10 баллов по Женевской шкале свидетельствовала о высокой вероятности развития ТЭЛА. Заключение. Исследование показало низкую ценность интегральных систем оценки вероятности наличия ТЭЛА в общей популяции больных с этим заболеванием. Авторы рекомендуют использовать двухуровневую систему интерпретации полученных результатов, в которой суммарная оценка более 6 баллов по Канадской шкале и 10 баллов по Женевской шкале отождествлялась с высокой вероятностью (до 80%) наличия ТЭЛА.</p></trans-abstract><kwd-group xml:lang="en"><kwd>pulmonary thromboembolism</kwd><kwd>diagnostic scales</kwd><kwd>validity</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>тромбоэмболия легочных артерий</kwd><kwd>диагностические шкалы</kwd><kwd>обоснованность</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>White R.H. The Epidemiology of Venous Thromboembolism. Circulation 2003; 107: I-4-I-8.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Kroegel C., Reissig A. Principle mechanisms underlying venous thromboembolism: epidemiology, risk factors, pathophysiology and pathogenesis. Respiration 2003; 70 (1): 7-30.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Wells P.S., Anderson D.R., Rodger M. et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000; 83 (3): 416-420.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Le Gal G., Righini M., Roy P.M. et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med 2006; 144 (3): 165-171.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Kabrhel C., McAfee A.T., Goldhaber S.Z. The contribution of the subjective component of the Canadian pulmonary embolism score to the overall score in emergency department patients. Acad Emerg Med 2005; 12: 915-920.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008; 29 (18): 2276-2315.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating (ROC) curve. Radiology 1982; 143: 29-36.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Klok F.A., Kruisman E., Spaan J. et al. Comparison of the revised Geneva score with the Wells rule for assessing clinical probability of pulmonary embolism. J Thromb Haemost 2008; 6 (1): 40-44.</mixed-citation></ref></ref-list></back></article>
